Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes
Mollie Jurewicz(Brigham and Women's Hospital), Reza Abdi(Brigham and Women's Hospital), Mohamed H. Sayegh(American University of Beirut), Paolo Fiorina(Boston Children's Hospital), Jonathan Godwin(DeepMind (United Kingdom)), Jamil Azzi(Brigham and Women's Hospital), Mark A. Atkinson(University of Florida), Andrea Augello(University of Insubria), Sunmi Yang(Brigham and Women's Hospital), Robert F. Moore(Brigham and Women's Hospital)
Cited by 152
Related Papers
International evaluation of an AI system for breast cancer screening
|Nature|2020|3.1k
Type 1 diabetes
|The Lancet|2013|2.7k
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k